T0	Participants 178 224	More than 50% of patients with Crohn's disease
T1	Participants 518 589	Patients with steroid-dependent Crohn's disease (n = 271) were enrolled
T2	Participants 644 925	Steroid dependence was defined as use of prednisolone or prednisone (15-40 mg/day) or budesonide (9 mg/day) for > or =8 weeks, a previous failed attempt to decrease or discontinue steroids within 8 weeks of screening, and a Crohn's Disease Activity Index score of < or =150 points.
T3	Participants 1135 1164	patients with steroid sparing
T4	Participants 1556 1604	patients with steroid-dependent Crohn's disease.